Literature DB >> 27225402

Clinical Features, Outcomes, and Molecular Characteristics of Community- and Health Care-Associated Staphylococcus lugdunensis Infections.

Chun-Fu Yeh1, Shih-Cheng Chang2, Chun-Wen Cheng3, Jung-Fu Lin3, Tsui-Ping Liu4, Jang-Jih Lu5.   

Abstract

Staphylococcus lugdunensis is a major cause of aggressive endocarditis, but it is also responsible for a broad spectrum of infections. The differences in clinical and molecular characteristics between community-associated (CA) and health care-associated (HA) S. lugdunensis infections have remained unclear. We performed a retrospective study of S. lugdunensis infections between 2003 and 2014 to compare the clinical and molecular characteristics of CA and HA isolates. We collected 129 S. lugdunensis isolates in total: 81 (62.8%) HA isolates and 48 (37.2%) CA isolates. HA infections were more frequent than CA infections in children (16.0% versus 4.2%, respectively; P = 0.041) and the elderly (38.3% versus 14.6%, respectively; P = 0.004). The CA isolates were more likely to cause skin and soft tissue infections (85.4% versus 19.8%, respectively; P < 0.001). HA isolates were more frequently responsible for bacteremia of unknown origin (34.6% versus 4.2%, respectively; P < 0.001) and for catheter-related bacteremia (12.3% versus 0%, respectively; P = 0.011) than CA isolates. Fourteen-day mortality was higher for HA infections than for CA infections (11.1% versus 0%, respectively). A higher proportion of the HA isolates than of the CA isolates were resistant to penicillin (76.5% versus 52.1%, respectively; P = 0.004) and oxacillin (32.1% versus 2.1%, respectively; P < 0.001). Two major clonal complexes (CC1 and CC3) were identified. Sequence type 41 (ST41) was the most common sequence type identified (29.5%). The proportion of ST38 isolates was higher for HA than for CA infections (33.3% versus 12.5%, respectively; P = 0.009). These isolates were of staphylococcal cassette chromosome mec element (SCCmec)type IV, V, or Vt. HA and CA S. lugdunensis infections differ in terms of their clinical features, outcome, antibiotic susceptibilities, and molecular characteristics.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27225402      PMCID: PMC4963507          DOI: 10.1128/JCM.00847-16

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  27 in total

1.  Rapid identification of Staphylococci isolated in clinical microbiology laboratories by matrix-assisted laser desorption ionization-time of flight mass spectrometry.

Authors:  Etienne Carbonnelle; Jean-Luc Beretti; Stéphanie Cottyn; Gilles Quesne; Patrick Berche; Xavier Nassif; Agnès Ferroni
Journal:  J Clin Microbiol       Date:  2007-05-16       Impact factor: 5.948

2.  Clinical significance of a single Staphylococcus lugdunensis-positive blood culture.

Authors:  Hind J Fadel; Robin Patel; Emily A Vetter; Larry M Baddour
Journal:  J Clin Microbiol       Date:  2011-01-26       Impact factor: 5.948

3.  Incidence, characteristics, and outcomes of Staphylococcus lugdunensis bacteremia.

Authors:  Seong-Ho Choi; Jin-Won Chung; Eun Jung Lee; Tae Hyong Kim; Mi Suk Lee; Jae Myung Kang; Eun Hee Song; Jae-Bum Jun; Mi-Na Kim; Yang Soo Kim; Jun Hee Woo; Sang-Ho Choi
Journal:  J Clin Microbiol       Date:  2010-06-30       Impact factor: 5.948

4.  Persistence of a major endemic clone of oxacillin-resistant Staphylococcus lugdunensis sequence type 6 at a tertiary medical centre in northern Taiwan.

Authors:  Chun-wen Cheng; Tsui-ping Liu; Chun-fu Yeh; Ming-hsun Lee; Shih-cheng Chang; Jang-jih Lu
Journal:  Int J Infect Dis       Date:  2015-06-04       Impact factor: 3.623

5.  Multilocus sequence typing analysis of Staphylococcus lugdunensis implies a clonal population structure.

Authors:  Benoît Chassain; Ludovic Lemée; Jennifer Didi; Jean-Michel Thiberge; Sylvain Brisse; Jean-Louis Pons; Martine Pestel-Caron
Journal:  J Clin Microbiol       Date:  2012-07-11       Impact factor: 5.948

6.  Using the tannase gene to rapidly and simply identify Staphylococcus lugdunensis.

Authors:  Norihisa Noguchi; Keiko Goto; Tokihiro Ro; Koji Narui; Mari Ko; Yutaka Nasu; Kenta Utsumi; Kenji Takazawa; Fuminori Moriyasu; Masanori Sasatsu
Journal:  Diagn Microbiol Infect Dis       Date:  2009-05-15       Impact factor: 2.803

7.  Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection.

Authors:  Timothy S Naimi; Kathleen H LeDell; Kathryn Como-Sabetti; Stephanie M Borchardt; David J Boxrud; Jerome Etienne; Susan K Johnson; Francois Vandenesch; Scott Fridkin; Carol O'Boyle; Richard N Danila; Ruth Lynfield
Journal:  JAMA       Date:  2003-12-10       Impact factor: 56.272

8.  Prevalence, identification, and antimicrobial susceptibility of Staphylococcus lugdunensis from various clinical specimens in Korea.

Authors:  Jeong Hwan Shin; Hee Jung Jung; Hi Ryune Lee; Jae Hyen Kim; Hye Ran Kim; Jeong Nyeo Lee
Journal:  Jpn J Infect Dis       Date:  2007-09       Impact factor: 1.362

Review 9.  Significance of Staphylococcus lugdunensis bacteremia: report of 28 cases and review of the literature.

Authors:  A S Zinkernagel; M S Zinkernagel; M V Elzi; M Genoni; J Gubler; R Zbinden; N J Mueller
Journal:  Infection       Date:  2008-07-21       Impact factor: 3.553

10.  Staphylococcus lugdunensis, a common cause of skin and soft tissue infections in the community.

Authors:  Sidsel Böcher; Birgitte Tønning; Robert L Skov; Jørgen Prag
Journal:  J Clin Microbiol       Date:  2009-02-25       Impact factor: 5.948

View more
  7 in total

1.  Comparison of the etiological relevance of Staphylococcus haemolyticus and Staphylococcus hominis.

Authors:  Hagen Frickmann; Andreas Hahn; Romy Skusa; Nils Mund; Vivian Viehweger; Thomas Köller; Kerstin Köller; Norbert Georg Schwarz; Karsten Becker; Philipp Warnke; Andreas Podbielski
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-05-19       Impact factor: 3.267

2.  Complete genome sequence of a methicillin-resistant Staphylococcus lugdunensis strain and characteristics of its staphylococcal cassette chromosome mec.

Authors:  Rie Shibuya; Yuki Uehara; Tadashi Baba; Kuniko Teruya; Kazuhito Satou; Takashi Hirano; Teruo Kirikae; Keiichi Hiramatsu
Journal:  Sci Rep       Date:  2020-05-26       Impact factor: 4.379

3.  Comparative Genome Analysis of Staphylococcus lugdunensis Shows Clonal Complex-Dependent Diversity of the Putative Virulence Factor, ess/Type VII Locus.

Authors:  Jérémie Lebeurre; Sandrine Dahyot; Seydina Diene; Amandine Paulay; Marion Aubourg; Xavier Argemi; Jean-Christophe Giard; Isabelle Tournier; Patrice François; Martine Pestel-Caron
Journal:  Front Microbiol       Date:  2019-10-31       Impact factor: 5.640

4.  Comparative Genomic Analyses Reveal Potential Factors Responsible for the ST6 Oxacillin-Resistant Staphylococcus lugdunensis Endemic in a Hospital.

Authors:  Shih-Cheng Chang; Lee-Chung Lin; Jang-Jih Lu
Journal:  Front Microbiol       Date:  2021-11-25       Impact factor: 5.640

5.  Molecular Epidemiological Survey of Staphylococcus lugdunensis Isolates With Variable Number of Repeats in the von Willebrand Factor-Binding Protein Gene.

Authors:  Lee-Chung Lin; Chun-Wen Cheng; Shih-Cheng Chang; Jang-Jih Lu
Journal:  Front Cell Infect Microbiol       Date:  2021-11-11       Impact factor: 5.293

6.  Antimicrobial Resistance and Antimicrobial Activity of Staphylococcus lugdunensis Obtained from Two Spanish Hospitals.

Authors:  Rosa Fernández-Fernández; Carmen Lozano; Laura Ruiz-Ripa; Beatriz Robredo; José Manuel Azcona-Gutiérrez; Carla Andrea Alonso; Carmen Aspiroz; Myriam Zarazaga; Carmen Torres
Journal:  Microorganisms       Date:  2022-07-22

7.  Multiple-Locus Variable Number Tandem Repeat Analysis (MLVA) and Tandem Repeat Sequence Typing (TRST), helpful tools for subtyping Staphylococcus lugdunensis.

Authors:  Sandrine Dahyot; Jérémie Lebeurre; Xavier Argemi; Patrice François; Ludovic Lemée; Gilles Prévost; Martine Pestel-Caron
Journal:  Sci Rep       Date:  2018-08-03       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.